Logan Zhang

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms”.

High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms

Frontiers in Oncology(2021)10.3389/fonc.2021.664236

N/A

0DataRank · unranked

37 citations

Zev A. Binder, Yibo Yin, Logan Zhang, Jiasi Vicky Zhang, Daniel Y. Zhang +5 more

High Affinity Chimeric Antigen Receptor with Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.04.429797

N/A

0DataRank · unranked

4 citations

Zev A. Binder, Yibo Yin, Logan Zhang, Jiasi Vicky Zhang, Daniel Y. Zhang +5 more

The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity

Molecular Therapy — Oncolytics(2022)10.1016/j.omto.2022.11.004

N/A

0DataRank · unranked

39 citations

Xin Wang, Benjamin Philipson, Qian Zhang, Radhika Thokala, Logan Zhang +7 more